Natalie Springveld has over 20 years of experience in clinical research and development, with a specialization in pharmacovigilance. They have held various leadership positions, including Medical Director at Pfizer, where they currently lead the PV & Drug Safety etrasimod program. Previously, they contributed to the approval of major medicinal products for multiple sclerosis and ulcerative colitis, and served as a Global Safety Leader at Bayer, as well as in other notable roles at companies such as Johnson & Johnson and Eli Lilly. Natalie holds an MD and is currently pursuing a PhD in Neuroscience, highlighting their commitment to advancing medical knowledge and safety in drug development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices